Trial NCT03565991

View at ClinicalTrials.gov 
Org. Study IDs: B9991032
Secondary IDs: 2018-000345-39

Last trial update was posted on 2023-09-25

MeSH Interventions

Avelumab Talazoparib

MeSH Conditions


Other Conditions

Genes, BRCA 1 Locally Advanced or Metastatic Solid Tumors

Stopping Reasons

The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID